Will you join our gene therapy in haemophilia symposium at EAHAD 2024?

The European Association for Haemophilia and Allied Disorders (EAHAD) Congress aims to exchange knowledge on inherited or acquired bleeding disorders to improve clinical care. The 17th annual EAHAD Congress will be held from Tuesday 6th to Friday 9th February 2024 in Frankfurt, Germany, with virtual access for registered delegates. There is still time to register here.

The most recent findings and current issues in the world of bleeding disorders will be presented by leading experts in their fields. Come and join us at EAHAD 2024 to discuss the latest news, exchange ideas, broaden your knowledge, and experience Frankfurt's beauty and diversity. You can view the EAHAD 2024 Organising Committee’s welcome letter and video here.

CSL Behring will be organising and supporting another symposium at EAHAD 2024, discussing patient and physician perspectives of the year following the European approval of the first gene therapy for haemophilia B, and discuss what steps need to be taken to bring gene therapy to patients. Join healthcare specialists Jan Astermark, Daan Breederveld and Priyanka Raheja in our upcoming satellite symposium “Unlocking the next step in gene therapy for haemophilia: The end of the beginning?” in-person or online on Wednesday 7th February; 11:45–13:00 CET. You can also watch our 2023 symposium ‘Gene therapy in haemophilia: the evolving patient-centric multidisciplinary journey’ on-demand here.

This interactive symposium was moderated by Michiel Coppens and featured discussions with Daan Breederveld, Lotte Haverman, Graham Foster and Kate Khair.